A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

Observational data suggested that men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle. A higher prostate cancer behavior score was associated with reductions in ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...

Patients say the difference it makes is amazing. A state-of-the-art laser prostate reduction operation is now being successfully delivered in the county as a day case procedure. HOLEP, or Holmium ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

To earn CME related to this news article, click here. February 25, 2009 — A new joint guideline produced by the American Society of Clinical Oncology (ASCO) and the American Urological Association ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

If you're facing a prostate cancer diagnosis, this guide to best dietary practices will help simplify your shopping list Getty What you eat can affect your prostate health, for better or worse.

Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment for patients with ...

Men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle, despite no reduction in prostate cancer-specific mortality, according to a large observational study. A ...